September 19, 2023 — A mathematical and computational model of the human heart entirely developed at Politecnico di Milano and designed for studying coronary artery disease. This is the focus of research published in the prestigious journal Nature Scientific Reports, entitled 'A comprehensive mathematical model for cardiac perfusion'.

September 18, 2023 — Pregnant women with a history of substance abuse face a dramatically increased risk of death from heart attack and stroke during 

September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced today the first cases with its investigational OMNYPULSE Catheter as part of the Omny-IRE clinical trial. The first procedures were performed by Dr. Mattias Duytschaever at AZ Sint-Jan Hospital in Brugge, Belgium.ii 

September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences, announced today that the 

For small and midsize business owners, creative and efficient marketing is a must-have — even with limited resources. 

Insider’s “Marketing for Small Business” is designed for  entrepreneurs and marketers looking to learn the latest strategies and techniques to grow their customer base. 

Hosted by senior entrepreneurship reporter, Jennifer Ortakales Dakins, this tactical bootcamp will give you actionable tips to maximize the ROI of your marketing efforts. You'll learn how to: 

September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease recently became the first in the United States and the Western Hemisphere to repair a heart valve with severe tricuspid regurgitation in a patient using the investigational 

September 15, 2023 — Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a significantly increased risk of 

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to this noninvasive diagnostic imaging tool may pose a greater risk to patients than rare side effects associated with use, according to doctors who spoke today at the 37th International 

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now